The longitudinal assessment of prenatal cannabis use on neonatal outcomes
Journal of Perinatology · 2024-08 · 44 (8) · 1152-1156
DOI: 10.1038/s41372-024-02027-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Perinatology, online erschienen am 18.06.2024. Verfasst von Leah L Habersham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, US. Leah.Habersham@mountsinai.org. Hauptthemen laut MEDLINE: Infant, Low Birth Weight, Fetal Death. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI), U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA), NIDA NIH HHS.
Abstract (Originalsprache)
Objective
To investigate the association between prenatal cannabis use and perinatal outcomes using longitudinal data from pregnant individuals. Study design This secondary-data analysis study utilized data collected from 894 pregnant individuals followed in the Stress in Pregnancy longitudinal study, conducted between 2009 and 2013. The status of cannabis use was ascertained through interviews and electronic medical record reviews to evaluate the effect of cannabis use on perinatal outcomes (NICU admission, preterm delivery, low birth weight, fetal death).
Results
Among participants analyzed, 13.1% used cannabis, who were generally younger (25.9 vs 27.9 years). There was a sevenfold increased risk of fetal death (OR 7.30) among cannabis users relative to non-users. Elevated risk persisted after adjustments of potential confounders (aOR 6.31). Adjusted models also suggested increased low birth weight risk (aOR 1.67).
Conclusion
This study highlights an association between prenatal cannabis use and elevated risks for fetal death and low birth weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, US. Leah.Habersham@mountsinai.org.
- Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY, US. Leah.Habersham@mountsinai.org.
- Addiction Institute of Mount Sinai, New York, NY, US. Leah.Habersham@mountsinai.org.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, US.
- Addiction Institute of Mount Sinai, New York, NY, US.
- Queens College and Graduate Center, The City University of New York, New York, NY, US.
ORCID-Profile: Leah L Habersham, Yoko Nomura
Förderung
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
- NIDA NIH HHS
- Addiction Institute of Mount Sinai internal funds
Zitieren
APA
Habersham, L. L., Hurd, Y. L., & Nomura, Y. (2024). The longitudinal assessment of prenatal cannabis use on neonatal outcomes. Journal of Perinatology, 44(8), 1152-1156. https://doi.org/10.1038/s41372-024-02027-w
Vancouver
Habersham LL, Hurd YL, Nomura Y. The longitudinal assessment of prenatal cannabis use on neonatal outcomes. Journal of Perinatology. 2024;44(8):1152-1156. doi:10.1038/s41372-024-02027-w
BibTeX
@article{Habersham2024,
author = {Habersham, Leah L and Hurd, Yasmin L and Nomura, Yoko},
title = {The longitudinal assessment of prenatal cannabis use on neonatal outcomes},
journal = {Journal of Perinatology},
year = {2024},
volume = {44},
number = {8},
pages = {1152--1156},
doi = {10.1038/s41372-024-02027-w}
}
EUVIMED